Results 11 to 20 of about 14,081 (169)

Genomic signature for oligometastatic disease in non-small cell lung cancer patients with brain metastases

Frontiers in Endocrinology
Purpose/objective(s)Biomarkers for extracranial oligometastatic disease remain elusive and few studies have attempted to correlate genomic data to the presence of true oligometastatic disease.MethodsPatients with non-small cell lung cancer (NSCLC) and ...
Ariel R. Choi, Ralph B. D’Agostino, Michael K. Farris, Mohammed Abdulhaleem, John C. Hunting, Yuezhu Wang, Margaret R. Smith, Jimmy Ruiz, Thomas W. Lycan, W. Jeffrey Petty, Christina K. Cramer, Stephen B. Tatter, Adrian W. Laxton, Jaclyn J. White, Wencheng Li, Jing Su, Christopher Whitlow, Fei Xing, Michael D. Chan   +18 more
doaj   +2 more sources

Oligometastatic non-small-cell lung cancer: current treatment strategies

Lung Cancer: Targets and Therapy, 2016
Patrick J Richard, Ramesh Rengan Department of Radiation Oncology, University of Washington, Seattle, WA, USA Abstract: The oligometastatic disease theory was initially described in 1995 by Hellman and Weichselbaum.
Richard PJ, Rengan R
doaj   +1 more source

Definitions and treatment of oligometastatic oesophagogastric cancer according to multidisciplinary tumour boards in Europe. [PDF]

, 2022
BACKGROUND Consensus about the definition and treatment of oligometastatic oesophagogastric cancer is lacking. OBJECTIVE To assess the definition and treatment of oligometastatic oesophagogastric cancer across multidisciplinary tumour boards ...
Roviello, Franco, Kroese, Tiuri E., Monig, Stefan, Hanna, George B., Wyrwicz, Lucjan, de Manzoni, Giovanni, Hawkings, Maria A., Markar, Sheraz, Chaudry, Asif, Guckenberger, Matthias, Pera, Manuel, Jeene, Paul, Gani, Cihan, Nieuwenhuijzen, Grard, Deseyne, Pieter R.AJ., Cheong, Edward, Adenis, Antoine, Gockel, Ines, Elme, Anneli, Morganti, Alessio, van Laarhoven, Hanneke W M, Pfeiffer, Per, Wagner, Dorethea, Deseyne, Pieter R A J, Hawkings, Maria A, Moehler, Markus, van Sandick, Johanna W., Kroese, Tiuri E, Beerepoot, Laurens, Berbee, Maaike, van Rossum, Peter S N, Rosati, Riccardo, Wijnhoven, Bas, Obermannova, Radka, van Sandick, Johanna W, Lordick, Florian, Hawkins, Maria A., van Rossum, Peter S.N., Bruns, Christiane J., Liakakos, Theodore, Polkowski, Wojciech P., Hawkins, Maria A, Kolodziejczyk, Piotr, Beerepoot, Laurens V., Deseyne, Pieter R.A.J., Griffiths, Ewen A., Muijs, Christel; id_orcid, D'Ugo, Domenico, Nordsmark, Marianne, Nilsson, Magnus, Bencivenga, Maria, van Hillegersberg, Richard, Polkowski, Wojciech P, Kanonnikoff, Tania F., Piessen, Guillaume, Pfeiffer, Per; id_orcid, Hanna, George B, van Laarhoven, Hanneke W.M., Castoro, Carlo, Slingerland, Marije, Muijs, Christel, Beerepoot, Laurens V, Alsina, Maria, Griffiths, Ewen A, Kołodziejczyk, Piotr, Schoppmann, Sebastian, Bruns, Christiane J, Kanonnikoff, Tania F, Verheij, Marcel, Nafteux, Philippe, Smyth, Elizabeth, Reynolds, John   +71 more
core   +13 more sources

Prostate cancer - what about oligometastatic disease and stereotactic ablative radiotherapy? - a narrative review [PDF]

, 2023
Background and Objective: Oligometastatic prostate cancer (OMPC) encompasses a heterogenous group of clinical entities defined by the timing of the development of metastases.
Boussios, S., Saxby, H., Mikropoulos, C.
core   +1 more source

Stereotactic ablative radiotherapy for oligometastatic prostate cancer [PDF]

, 2022
Background: The present study assessed clinical outcomes of stereotactic body radiotherapy (SBRT) in oligometastatic prostate cancer patients. Materials and methods: Between 2017 and 2020, 37 lesions (12 osseous and 25 nodal targets) detected with ...
Ferrara E., Beldi D., Gallizia E., Zannetti M., Franco P., Gennari A., Krengli M., Loi G.   +7 more
core   +2 more sources

Definitive local therapy to head and neck squamous cell carcinoma with distant metastasis

Laryngoscope Investigative Otolaryngology, 2022
Objectives Data on the efficacy of including definitive local therapy to the primary site for head and neck squamous cell carcinoma (HNSCC) patients with synchronous distant metastasis are lacking.
Steven Borson, Yongli Shuai, Barton F. Branstetter, Marci Lee Nilsen, Marion A. Hughes, Moon Fenton, Mark Kubik, Shaum Sridharan, David A. Clump, Heath D. Skinner, Jonas T. Johnson, Simion I. Chiosea, James Ohr, Umamaheswar Duvvuri, Seungwon Kim, Katie S. Traylor, Robert Ferris, Dan P. Zandberg   +17 more
doaj   +1 more source

Highlighting the Place of Metastasis-Directed Therapy in Isolated Liver Metastases in Prostate Cancer: A Case Report

Frontiers in Oncology, 2021
Metastatic prostate cancer remains a challenge for clinicians. Metastases involve mainly the bone compartment and can manifest as oligometastatic disease.
Anne-Emmanuella Yeo, Aurore Hendrix, Caterina Confente, Nicolas Christian, Baudouin Mansvelt, Géraldine Pairet, Emmanuel Seront   +6 more
doaj   +1 more source

First-Line Tyrosine Kinase Inhibitors Combined With Local Consolidative Radiation Therapy for Elderly Patients With Oligometastatic Non-Small Cell Lung Cancer Harboring EGFR Activating Mutations

Frontiers in Oncology, 2022
ObjectiveThe aim of this study was to investigate the efficacy and safety of combined applications of local consolidative radiation therapy (LCRT) and first-line tyrosine kinase inhibitors (TKIs) for the treatment of primary tumors and oligometastatic ...
Xiaolong Hu, Hongqi Li, Xiaoli Kang, Xuan Wang, Haifeng Pang, Chen Liu, Jianchun Zhang, Yingjie Wang   +7 more
doaj   +1 more source

Oligometastatic breast cancer: Are we there yet? [PDF]

, 2021
Patients with metastatic breast cancer are usually considered incurable. Recent advances have resulted in significant improvements in survival for patients with metastatic breast cancer.
Catherine M. Kelly, Maha AlSendi, AlSendi, Maha, Youssef H. Zeidan, Kelly, Catherine Margaret A., David O'Reilly, O’Reilly, David E., Zeidan, Youssef H.   +7 more
core   +1 more source

Survival benefit of local consolidative therapy for patients with single-organ metastatic pancreatic cancer: a propensity score-matched cross-sectional study based on 17 registries

Frontiers in Endocrinology, 2023
BackgroundThe continuous exploration of oligometastatic disease has led to the remarkable achievements of local consolidative therapy (LCT) and favorable outcomes for this disease.
Xiaolong Hu, Dan Hu, Bowen Fu, Hongqi Li, Gang Ren, Hefei Liu, Jiazhao Song, Xiaoli Kang, Xuan Wang, Haifeng Pang, Chen Liu, Jianchun Zhang, Yingjie Wang   +12 more
doaj   +1 more source